Coccidiosis is one of the most prevalent parasitic diseases of domesticated animals, and its symptoms include weight loss, mild intermittent to severe diarrhea, and feces containing blood or mucus, dehydration, and reduced breeding. Coccidiosis is usually caused by single-celled parasites (protozoa) called Eimeria, which undergo a simple life cycle in the gut. Anticoccidial drugs play an essential role in the prevention and treatment of coccidiosis. Thus, the increasing incidences of coccidiosis are giving the key players lucrative opportunities to manufacture the anticoccidial drugs over the period of forecast.
The increased incidence of coccidiosis drives Anticoccidial Drugs market growth in food-producing animals, and companion animals, advancements in veterinary healthcare, innovative animal healthcare product launches have also gained popularity, especially in the companion animals sector, the worldwide increase in demand for proteins.
However, the availability of alternative treatment options in the market, the massive money in the treatment and prevention of coccidiosis, growing resistance of the pathogens are expected to restrain the market growth.
Growing number of regulations and bans on the use of anticoccidial drugs along with the related costs in developing new drugs increase the need for the development of novel approaches and alternative control strategies for coccidiosis.
Based on drug type, the Anticoccidial Drugs Market is segmented into Ionophore Anticoccidials, Chemical Derivative Anticoccidials. Ionophore anticoccidial segment is expected to boost the market. For instance, a significant breakthrough in the prevention of coccidiosis through the feed medication in 1972, with the initial launch of the first polyether ionophore anticoccidial, known as monensin. Ionophores are fermentation products of Streptomyces and other fungi species; and are the most widely used drugs for coccidiosis prevention due to its broad-spectrum activity against the majority of pathogenic species of coccidians. Due to the factors mentioned above, the ionophore anticoccidial segment is expected to experience healthy growth during the forecast period.
Based on animal type, the Anticoccidial Drugs Market is segmented into poultry, swine, and others. The global poultry industry is considered most affected by coccidiosis as it causes the annual industry loss that has been estimated to exceed US$ 3 billion per year.
Geographically, the market is divided into North America, Europe, South America, Asia-Pacific and the Middle East and Africa.
North America is dominating the Anticoccidial Drugs market in 2018 and estimated to hold largest market size over the forecast period (2019-2026). This is owing to the availability of anticoccidial drugs, awareness for the prevention of coccidiosis, safe animal food supply, and high investment in R&D in developing novel products are likely to propel the North America Anticoccidial Drugs market during the forecast period.
Europe is the significant region of the anticoccidial drugs market, owing to a highly developed health care industry, significant government funds for the development of veterinary medicines, growing awareness among people, and high consumption of meat. The Biotechnology and Biological Sciences Research Council has donated GBP 5.7 Million for the development of vaccines of poultry to the London School of Hygiene and Tropical Medicine in December 2015.
Some of the major players in the anticoccidial drugs market are Bayer Animal Healthcare, Boehringer Ingelheim, Ceva Animal Health Inc., Elanco Animal Health (a subsidiary of Eli Lilly), Merck, Merial, Virbac, Zoetis Animal Healthcare, Vetoquinol SA, and others.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
